Published in Circulation on March 01, 1992
Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature (2014) 3.31
Calcium and arrhythmogenesis. Physiol Rev (2007) 2.76
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest (2003) 2.56
BIN1 localizes the L-type calcium channel to cardiac T-tubules. PLoS Biol (2010) 2.34
Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)). J Physiol (2003) 2.19
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A (2006) 2.05
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci U S A (2005) 1.99
A computational model of the human left-ventricular epicardial myocyte. Biophys J (2004) 1.88
Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure. Circulation (2011) 1.80
Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling. Heart Rhythm (2010) 1.79
Excitation-contraction coupling and mitochondrial energetics. Basic Res Cardiol (2007) 1.74
The L-type calcium channel in the heart: the beat goes on. J Clin Invest (2005) 1.73
Changes in the organization of excitation-contraction coupling structures in failing human heart. PLoS One (2011) 1.59
Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. J Clin Invest (1996) 1.56
Targeting phospholamban by gene transfer in human heart failure. Circulation (2002) 1.55
Enhanced ryanodine receptor-mediated calcium leak determines reduced sarcoplasmic reticulum calcium content in chronic canine heart failure. Biophys J (2007) 1.48
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia. Cardiovasc Res (2015) 1.46
Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest (1996) 1.44
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology. J Mol Cell Cardiol (2009) 1.42
Calmodulin kinase is a molecular switch for cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2001) 1.34
Spontaneous calcium release in tissue from the failing canine heart. Am J Physiol Heart Circ Physiol (2009) 1.25
Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction. J Physiol (1999) 1.23
Increased Ca(2+) leak and spatiotemporal coherence of Ca(2+) release in cardiomyocytes during beta-adrenergic stimulation. J Physiol (2009) 1.22
Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart. Heart Fail Rev (2009) 1.19
Na+-Ca2+ exchange and sarcoplasmic reticular Ca2+ regulation in ventricular myocytes from transgenic mice overexpressing the Na+-Ca2+ exchanger. J Physiol (1998) 1.19
Alterations in action potential profile enhance excitation-contraction coupling in rat cardiac myocytes. J Physiol (2001) 1.17
mRNA expression levels in failing human hearts predict cellular electrophysiological remodeling: a population-based simulation study. PLoS One (2013) 1.16
Heart failure -- a challenge to our current concepts of excitation-contraction coupling. J Physiol (2003) 1.14
CaMKII-induced shift in modal gating explains L-type Ca(2+) current facilitation: a modeling study. Biophys J (2009) 1.08
Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability. J Clin Invest (1995) 1.08
Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIδ(C) can be reversed by inhibition of late Na(+) current. Basic Res Cardiol (2010) 1.06
Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart: primary defects in SR Ca2+ uptake and release mechanisms. Am J Physiol Heart Circ Physiol (2006) 1.05
Cardiac gene therapy with SERCA2a: from bench to bedside. J Mol Cell Cardiol (2010) 1.05
Calcium cycling proteins and force-frequency relationship in heart failure. Basic Res Cardiol (1996) 1.05
Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase. J Physiol (2006) 0.98
Calcium dynamics in the ventricular myocytes of SERCA2 knockout mice: A modeling study. Biophys J (2011) 0.97
SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr (2005) 0.94
Simulation and mechanistic investigation of the arrhythmogenic role of the late sodium current in human heart failure. PLoS One (2012) 0.93
Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction. J Am Heart Assoc (2013) 0.93
Reduced contraction strength with increased intracellular [Ca2+] in left ventricular trabeculae from failing rat hearts. J Physiol (2003) 0.93
Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility. J Clin Invest (2002) 0.92
Remodeling of calcium handling in human heart failure. Adv Exp Med Biol (2012) 0.91
Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo. Am J Physiol Heart Circ Physiol (2008) 0.91
Phospholamban overexpression in transgenic rabbits. Transgenic Res (2007) 0.91
Bradycardia alters Ca(2+) dynamics enhancing dispersion of repolarization and arrhythmia risk. Am J Physiol Heart Circ Physiol (2013) 0.91
A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids. Hum Mutat (2008) 0.91
Determination of rate constants for turnover of myosin isoforms in rat myocardium: implications for in vivo contractile kinetics. Am J Physiol Heart Circ Physiol (2009) 0.91
Triple threat: the Na+/Ca2+ exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure. Curr Drug Targets (2011) 0.90
Effect of cyclopiazonic acid, an inhibitor of sarcoplasmic reticulum Ca(2+)-ATPase, on the frequency-dependence of the contraction-relaxation cycle of the guinea-pig isolated atrium. Br J Pharmacol (1994) 0.90
Accurate quantitation of phospholamban phosphorylation by immunoblot. Anal Biochem (2012) 0.89
Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology. PLoS One (2012) 0.89
Efficient preloading of the ventricles by a properly timed atrial contraction underlies stroke work improvement in the acute response to cardiac resynchronization therapy. Heart Rhythm (2013) 0.88
Right ventricular arrhythmogenesis in failing human heart: the role of conduction and repolarization remodeling. Am J Physiol Heart Circ Physiol (2012) 0.88
Treating relentlessly progressive congestive heart failure: what next? Tex Heart Inst J (1998) 0.87
The usefulness of surface electrocardiogram as a prognostic predictor in children with idiopathic dilated cardiomyopathy. J Korean Med Sci (2004) 0.86
Role of PP1 in the regulation of Ca cycling in cardiac physiology and pathophysiology. Front Biosci (Landmark Ed) (2009) 0.86
Uniformity of calcium channel number and isometric contraction in human right and left ventricular myocardium. Basic Res Cardiol (1994) 0.85
Adult progenitor cell transplantation influences contractile performance and calcium handling of recipient cardiomyocytes. Am J Physiol Heart Circ Physiol (2009) 0.85
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc Res (2015) 0.85
Effects of low-level α-myosin heavy chain expression on contractile kinetics in porcine myocardium. Am J Physiol Heart Circ Physiol (2011) 0.85
Mechanism of the diastolic dysfunction induced by glycolytic inhibition. Does adenosine triphosphate derived from glycolysis play a favored role in cellular Ca2+ homeostasis in ferret myocardium? J Clin Invest (1994) 0.84
Non-steady-state calcium handling in failing hearts from the spontaneously hypertensive rat. Pflugers Arch (2010) 0.84
PDE3 inhibition in dilated cardiomyopathy. Curr Opin Pharmacol (2011) 0.84
Generation and characterization of a lysosomally targeted, genetically encoded Ca(2+)-sensor. Biochem J (2013) 0.83
Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium. Pflugers Arch (2003) 0.83
SERCA2a gene therapy in heart failure: an anti-arrhythmic positive inotrope. Br J Pharmacol (2014) 0.82
Ca(2+) current facilitation is CaMKII-dependent and has arrhythmogenic consequences. Front Pharmacol (2014) 0.82
Modeling tissue- and mutation- specific electrophysiological effects in the long QT syndrome: role of the Purkinje fiber. PLoS One (2014) 0.81
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. Heart Fail Rev (2002) 0.81
Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats. J Transl Med (2012) 0.81
Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study. PLoS One (2014) 0.80
Regulatory effect of connexin 43 on basal Ca2+ signaling in rat ventricular myocytes. PLoS One (2012) 0.80
Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy. Mol Cell Biochem (1997) 0.80
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. J Vis Exp (2014) 0.80
Synergistic role of ADP and Ca(2+) in diastolic myocardial stiffness. J Physiol (2015) 0.80
Calcium handling proteins: structure, function, and modulation by exercise. Heart Fail Rev (2014) 0.79
[Ca2+]i in human heart failure: a review and discussion of current areas of controversy. Yale J Biol Med (1996) 0.79
[Reverse remodeling of the intracellular Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of heart failure]. Wien Med Wochenschr (2006) 0.79
Quantifying inter-species differences in contractile function through biophysical modelling. J Physiol (2015) 0.79
Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes. J Proteomics (2012) 0.79
Ion channels, transporters, and pumps as targets for heart failure therapy. J Cardiovasc Pharmacol (2009) 0.78
Beta blockers as anti-arrhythmic agents. Heart Fail Rev (2004) 0.78
Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure. Br J Pharmacol (2015) 0.78
Left ventricular dysfunction is associated with prolonged average ventricular fibrillation cycle length in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol (2002) 0.77
Evaluation of the regional responsivity to ryanodine of human myocardium from patients with idiopathic dilated cardiomyopathy and secondary cardiomyopathies. Basic Res Cardiol (1997) 0.77
Regulation of intracellular Na(+) in health and disease: pathophysiological mechanisms and implications for treatment. Glob Cardiol Sci Pract (2013) 0.77
Intracellular calcium and the relationship to contractility in an avian model of heart failure. J Comp Physiol B (2000) 0.77
Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction. Br J Pharmacol (2005) 0.77
Altered inotropism in the failing human myocardium. Basic Res Cardiol (1996) 0.76
Ryanodine receptor patents. Recent Pat Biotechnol (2012) 0.76
Abnormal calcium handling and exaggerated cardiac dysfunction in mice with defective vitamin d signaling. PLoS One (2014) 0.76
Aerobic interval training partly reverse contractile dysfunction and impaired Ca2+ handling in atrial myocytes from rats with post infarction heart failure. PLoS One (2013) 0.76
Fibroblast proliferation alters cardiac excitation conduction and contraction: a computational study. J Zhejiang Univ Sci B (2014) 0.76
Targeting device therapy: genomics of sudden death. Heart Fail Clin (2010) 0.76
Age and hypertrophy related changes in contractile post-rest behavior and action potential properties in isolated rat myocytes. Age (Dordr) (2007) 0.76
Post-translational Modifications in Heart Failure: Small Changes, Big Impact. Heart Lung Circ (2015) 0.75
Effects of Modified Parvalbumin EF-Hand Motifs on Cardiac Myocyte Contractile Function. Biophys J (2016) 0.75
Beta-Adrenoceptor Stimulation Reveals Ca2+ Waves and Sarcoplasmic Reticulum Ca2+ Depletion in Left Ventricular Cardiomyocytes from Post-Infarction Rats with and without Heart Failure. PLoS One (2016) 0.75
Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD). Physiol Rep (2016) 0.75
Calciotropic and Phosphaturic Hormones in End-Stage Heart Failure Patients Supported by a Left-Ventricular Assist Device. PLoS One (2016) 0.75
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 2.94
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Dtsch Med Wochenschr (2007) 2.67
Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation (1998) 2.48
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
[The central venous catheter. Approach to the subclavian vein]. Dtsch Med Wochenschr (2007) 2.04
[Ascites paracentesis]. Dtsch Med Wochenschr (2007) 2.03
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol (1998) 1.64
CT and MR evaluation of pericardial constriction: a new diagnostic and therapeutic concept. J Thorac Imaging (1993) 1.64
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol (1999) 1.63
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J (2011) 1.60
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 1.55
Congenitally corrected transposition of the great arteries (L-TGA) with situs inversus totalis in adulthood: findings with magnetic resonance imaging. Magn Reson Imaging (2000) 1.52
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. J Physiol (1975) 1.42
Xamoterol and the failing heart. Lancet (1989) 1.41
[About science and politics]. Dtsch Med Wochenschr (2003) 1.41
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol (1999) 1.40
[Therapy with glitazones--a risk for cardiovascular disease?]. Dtsch Med Wochenschr (2007) 1.40
[Epileptic seizures: effects on cardiac function]. Dtsch Med Wochenschr (2011) 1.40
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Med Wkly (2009) 1.39
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. Dtsch Med Wochenschr (1998) 1.39
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. Dtsch Med Wochenschr (1999) 1.39
[Death due to liver hemorrhage after infarct lysis]. Dtsch Med Wochenschr (1999) 1.38
[Stable angina pectoris can be treated successfully by drugs alone--pro]. Dtsch Med Wochenschr (2007) 1.38
[Clinical value of magnetic resonance tomography in imaging coronary stenoses. A comparison with coronary angiography and myocardial scintigraphy]. Dtsch Med Wochenschr (1999) 1.38
[Missing medical care?]. Dtsch Med Wochenschr (2002) 1.38
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1998) 1.22
Positive inotropism of vanadate in cat papillary muscle. Nature (1978) 1.18
Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol (1992) 1.18
Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. Biochim Biophys Acta (1973) 1.15
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol (1996) 1.12
Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation (1999) 1.11
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J (1988) 1.10
Thalidomide-induced symptomatic third-degree atrioventricular block. Clin Res Cardiol (2006) 1.10
Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol (1994) 1.10
Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol (1980) 1.08
Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J (1990) 1.06
Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. Biochim Biophys Acta (1980) 1.05
Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet (1992) 1.04
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. J Clin Invest (1996) 1.04
Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol (1997) 1.01
[Characteristics of patients with coronary ectasias with and without stenotic coronary artery disease]. Dtsch Med Wochenschr (2005) 1.01
Stimulatory effect of vanadate on the adenylate cyclase of cardiac tissue. Biochem Pharmacol (1979) 0.99
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol (1996) 0.99
Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1991) 0.99
Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J (1995) 0.99
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res (1991) 0.99
Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation. J Cardiovasc Pharmacol (1988) 0.98
Alcohol and the risk of myocardial infarction. Basic Res Cardiol (2001) 0.97
Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol (1995) 0.97
Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest (1990) 0.95
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J (2004) 0.94
cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res (1994) 0.94
Echinococcus cyst located in the interventricular septum. Clin Res Cardiol (2006) 0.94
Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci (1988) 0.93
Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.93
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. Am Heart J (1990) 0.93
[Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]. Dtsch Med Wochenschr (2007) 0.93
Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol (1988) 0.92
Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail (2005) 0.92
Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalaemia. Acta Biol Med Ger (1977) 0.91
Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res (1989) 0.90
Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation. Nature (1979) 0.90
Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J (1996) 0.90
Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. II. Effect of cations and nucleotides on rate constants and dissociation constants. Biochim Biophys Acta (1973) 0.89
Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor? Clin Investig (1993) 0.89
Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail (2004) 0.89
International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. Heart European Leaders Panel. J Cardiovasc Risk (1999) 0.88
Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. J Mol Cell Cardiol (1990) 0.88
Na+ channel activators as positive inotropic agents for the treatment of chronic heart failure. Cardiovasc Drugs Ther (2001) 0.88
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J (1992) 0.88
ADP binding to (Na++K+)-activated ATPase. Biochim Biophys Acta (1973) 0.88
Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur J Clin Invest (1991) 0.87
Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Z Kardiol (2003) 0.86
Electrical heterogeneity in the ventricular wall--and the M cell. Cardiovasc Res (1998) 0.86
Reduced positive inotropic effects in diseased human ventricular myocardium. Cardiovasc Res (1986) 0.86
Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension. Hypertension (1992) 0.86
Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure. Am J Med (1995) 0.85
Cardiac glycoside receptors in cultured heart cells--II. Characterization of a high affinity and a low affinity binding site in heart muscle cells from neonatal rats. Biochem Pharmacol (1984) 0.85
Influence of digitalis and diuretics on ouabain binding sites on human erythrocytes. Klin Wochenschr (1984) 0.85
Purified cardiac cell membranes with high (Na+ + K+)ATPase activity contain significant NADH-vanadate reductase activity. Nature (1979) 0.85
Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. A contribution to the problem of nonlinear Scatchard plots. Biochim Biophys Acta (1976) 0.85
Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. Eur Respir J (2006) 0.84